GPT and cancer: Lee et al. indicated that the AST/ALT ratio (≥ 1.5) is an independent prognostic factor associated with a worse prognosis of disease progression, overall mortality, and cancer-specific mortality in patients with nonmetastatic renal cell carcinoma [12].